COMMUNIQUÉS West-GlobeNewswire

Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases

20/02/2018 - 11:00

Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases Alliance aims to shorten the often multi-year journey that patients and families endure before being [...]

Photocure ASA: Presentation of the fourth quarter and full year 2017 results

20/02/2018 - 10:54

Photocure will present its fourth quarter and full year 2017 report on Tuesday 27 February 2018 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will be [...]

Lundbeck increases its share capital by 8,668 shares (0.0044 % of outstanding shares) as a result of exercise of employee warrants

20/02/2018 - 10:49

Valby, Denmark, 2018-02-20 10:49 CET (GLOBE NEWSWIRE) -- Valby, Denmark, 20 February 2018 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 43,340 as a consequence of [...]

Announcement no. 3/2018 - Share Buyback Programme

20/02/2018 - 10:44

Announcement no. 03/2018 20 February 2018 Coloplast initiates DKK 1bn share buy-back Coloplast is launching a share buy-back programme of up to DKK 1bn. The first part of the programme, of DKK 500m, is expected to take [...]

Veritas Intends to Complete the 100% Takeover of Cannevert Therapeutics in Q1

20/02/2018 - 09:10

VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) , (“Veritas” or the “Company”) is pleased to announce the Company and its research arm, [...]

Zealand Pharma and UniQuest collaborate to develop novel drug candidates for gastrointestinal diseases

20/02/2018 - 09:09

Company announcement - No. 04 / 2018 Zealand Pharma and UniQuest collaborate to develop novel drug candidates for gastrointestinal diseases Combining Zealand's expertise in discovery and development of peptide [...]

Changes to Biohit Oyj’s Management Team

20/02/2018 - 08:30

Biohit Oyj Company release, 20 th February, 2018 at 9.30 a.m. local time (EET) Biohit Oyj CFO Niklas Nordström is joining another company. Search for the new CFO is ongoing. For the time being, the Chief Financial [...]

DBV Technologies Reports December 31, 2017 Cash Position

20/02/2018 - 07:31

Press Release Montrouge, France, February 20, 2018 DBV Technologies Reports December 31, 2017 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its cash and [...]

DBV Technologies publie sa position de trésorerie au 31 décembre 2017

20/02/2018 - 07:31

Communiqué de Presse Montrouge, France, le 20 février 2018 (7h30 CET) DBV Technologies publie sa position de trésorerie au 31 décembre 2017 DBV Technologies, (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), [...]

CLINUVEL unveils new global positioning

20/02/2018 - 04:47

MELBOURNE, Australia, Feb. 19, 2018 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX:CUV) (XETRA-DAX:UR9) (NASDAQ INTERNATIONAL DESIGNATION ADR:CLVLY) today released its new global Company positioning including the [...]

Adamas Announces Declaratory Judgment Action Filed by Osmotica Related to Approved OSMOLEX ER

20/02/2018 - 02:01

EMERYVILLE, Calif., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS ) announced today that it has learned that Osmotica Pharmaceuticals LLC and Vertical Pharmaceuticals LCC (Osmotica) filed [...]

Burcon Announces Details of Completed Rights Offering

19/02/2018 - 19:39

VANCOUVER, British Columbia, Feb. 19, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (" Burcon ") is pleased to announce that, further to its press release dated February 14, 2018 [...]

FDA Approves Osmotica Pharmaceutical’s Once-Daily OSMOLEX ER™ (amantadine) extended-release tablets for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions in Adults

19/02/2018 - 19:00

BRIDGEWATER, N.J., Feb. 19, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceutical US LLC (“Osmotica” or the “Company”), a privately-held specialty pharmaceutical company developing novel central nervous system (CNS) [...]

BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at Two Upcoming Healthcare Investor Conferences

19/02/2018 - 19:00

RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., Feb. 19, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), and Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ), today announced they will be presenting at [...]

Sanofi: Disclosure of trading in own shares

19/02/2018 - 17:41

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/5f7e1210-1c87-4466-91ad-c83329e827dd

Sanofi : Déclaration des transactions sur actions propres

19/02/2018 - 17:41

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/41c2db5d-2733-40d9-9be1-05b72b1bafd8

Ossur Hf : Transactions in relation to share buyback program

19/02/2018 - 17:01

Announcement from Össur hf. No. 11/2018 Reykjavík, 19 February 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Transactions under Novozymes’ stock buyback program

19/02/2018 - 16:04

Please read the full announcement in the attached PDF http://prlibrary-eu.nasdaq.com/Resource/Download/fe173723-e6ca-4eb1-9177-48696a6c841e

Notice to convene annual general meeting 2018 of GN Store Nord

19/02/2018 - 14:16

Please find enclosed notice of GN Store Nord A/S’ annual general meeting 2018, including the complete proposals for the agenda. For further information, please contact: Investors and analysts Peter Justesen VP – [...]